Powered by RND
PoddsändningarNyheterMendelspod Podcast

Mendelspod Podcast

Theral Timpson
Mendelspod Podcast
Senaste avsnittet

Tillgängliga avsnitt

5 resultat 493
  • From Discovery to Translation: Bruker's Bold New Play in Spatial with Joe Beechem and Oliver Braubach
    “We’re going to be rewriting the textbooks on how tissues work.”In this compelling reunion with spatial biology pioneer Joe Beechem and a first-time visit from Oliver Braubach, we explore the rapid evolution of spatial technologies at Bruker, a legacy instrumentation company newly resurgent in the spatial space. Following Bruker’s acquisition of Nanostring and Canopy, the company has emerged as a unifying platform where whole-transcriptome discovery meets translational assay development—under one roof.* 0:00 Red alert: we don’t yet understand how tissue biology works, and don’t let anyone tell you we do.* 5:12 Customer of spatial turned toolmaker* 10:00 What do you want researchers to know about Bruker Spatial?* 14:24 How do you go from discovery to assay?* 18:09 How has AI impacted spatial?* 22:41 The ongoing question of reductionism* 31:00 What’s your biggest challenge?Beechem, known for launching the first high-plex spatial platform at Nanostring, returns to Mendelspod to declare that spatial biology may be more consequential than genomics itself. “If somebody tells you they understand how tissue biology works, you can just cut them off. They don’t,” he says, describing the dramatic leaps from 84-plex in 2019 to 20,000-plex subcellular imaging today.Braubach, a neuroscientist turned toolmaker, shares his journey from early customer to R&D leader, developing user-friendly platforms that empower researchers with flexibility and speed. “We want researchers to assume again a degree of power over their assays,” he says, outlining Bruker Spatial’s mission to integrate discovery and translation.Together, the two leaders discuss how AI is accelerating the power of spatial, with foundational models that can identify patterns humans can’t. Beechem recounts feeding high-plex images into a GPT model: “It came back and told me where to look. And it was right.”They also reflect on the philosophical shift spatial enables—moving beyond genomics' reductionist lens toward a more holistic view of biology in situ. “The hype around spatial is not hype,” says Beechem. “It’s real.” This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
    --------  
    35:44
  • Tagomics Wins NHS Grant, Unveils De-Methylation Platform for Early Cancer Testing with Rob Neely, CSO
    This is a free preview of a paid episode. To hear more, visit www.mendelspod.comIn this episode of Mendelspod, Theral sits down with Rob Neely, co-founder and CSO at Tagomics, to discuss how his company is fusing genomics, epigenomics, and fragmentomics into a single, assumption-free assay for early cancer detection. The conversation begins with breaking news: Tagomics has just received a new grant from the UK’s Innovation Agency a…
    --------  
    4:53
  • From Paris to the Pentagon: Sophie Peresson Maps Biosecurity’s New Landscape
    This is a free preview of a paid episode. To hear more, visit www.mendelspod.comIn this premium episode of Mendelspod, we’re joined by one of the few people speaking clearly and globally about biosecurity in the era of synthetic biology and AI: Sophie Peresson.A consultant and leader in responsible innovation, Sophie brings an unusually broad and grounded perspective. With experience spanning international law and governance, she p…
    --------  
    4:21
  • From Mitochondria to Protein Degradation: Mike Kiebish on BPGbio’s "Biology First" Vision
    This is a free preview of a paid episode. To hear more, visit www.mendelspod.comAs artificial intelligence continues to influence the life sciences, some researchers are questioning not just what it can predict, but what it can explain. On this episode, Mike Kiebish, VP of Platform and Translational Sciences at BPGbio, discusses the company’s “biology-first” approach to drug discovery—one that begins not with models or literature, …
    --------  
    4:26
  • The Grammar of RNA: Gavin Knott on Gene Editing and Structural Biology in the Age of AI
    In this episode of Mendelspod, we plunge into the shape-shifting world of RNA with Dr. Gavin Knott, associate professor at Monash University and alum of Jennifer Doudna’s lab. Knott is part of a new generation of researchers setting structural biology ablaze with AI, decoding RNA-guided systems and expanding the CRISPR toolbox far beyond its original scope.Knott introduces the listener to RNA not just as code, but as living language. He discusses how AI now allows scientists to see molecules in 3D at the beginning of a project rather than years into it: “You can take that protein sequence, run it through something like AlphaFold, and there it is, looking at you.”* 0:00 RNA - the shapeshifting paradox of a molecule* 4:05 Using AI: here’s an idea—maybe we know enough about biology* 6:50 The ARC Institute, and that one paper* 9:05 Structural biology at everyone’s fingertips* 18:10 Why are gene therapy companies going so slow?* 23:40 The grammar of RNAWith infectious curiosity, Knott explains how protein design is entering an era of intent, not just discovery. “Maybe we understand enough about the rules of biology,” he posits, “that we can design the proteins we need.” He describes his lab’s twin tracks: mining microbial genomes for novel RNA-guided machines and using generative AI tools like RosettaFold and BindSpace to build bespoke editors of DNA and RNA.The conversation touches on emerging efforts to mitigate off-target effects in gene editing using AI, the data limitations holding back RNA-protein modeling, and a powerful metaphor comparing static protein images to photos of horses.Knott makes a striking point: “We’ve known the spelling of RNA for a while, but now we’re trying to learn its grammar.” This, he explains, means understanding not just RNA’s sequence but its shape, movement, and silent punctuation marks—an effort he sees as the next frontier. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe
    --------  
    31:29

Fler podcasts i Nyheter

Om Mendelspod Podcast

Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine. www.mendelspod.com
Podcast-webbplats

Lyssna på Mendelspod Podcast, Expressen Dok och många andra poddar från världens alla hörn med radio.se-appen

Hämta den kostnadsfria radio.se-appen

  • Bokmärk stationer och podcasts
  • Strömma via Wi-Fi eller Bluetooth
  • Stödjer Carplay & Android Auto
  • Många andra appfunktioner

Mendelspod Podcast: Poddsändningar i Familj

Sociala nätverk
v7.21.0 | © 2007-2025 radio.de GmbH
Generated: 7/14/2025 - 11:12:13 AM